Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233


Dietary alterations modulate the microRNA 29/30 and IGF-1/AKT signaling axis in breast Cancer liver metastasis.

Shastri AA, Saleh A, Savage JE, DeAngelis T, Camphausen K, Simone NL.

Nutr Metab (Lond). 2020 Mar 23;17:23. doi: 10.1186/s12986-020-00437-z. eCollection 2020.


The prevalence of altered body image in patients with primary brain tumors: an understudied population.

Rowe L, Vera E, Acquaye A, Crandon S, Shah V, Bryla C, Wu J, Wall K, Siegel C, Reyes J, Penas-Prado M, Leggiero N, Cordova C, Burton E, Antony R, Boris L, Aboud O, Vyas Y, Mathen P, Gilbert M, Camphausen K, Mendoza T, Armstrong T.

J Neurooncol. 2020 Feb 24. doi: 10.1007/s11060-020-03433-8. [Epub ahead of print]


Twenty-five-Year Follow-up of a Prospective Randomized Trial Comparing Preoperative Versus Postoperative FLAC/Granulocyte Colony-Stimulating Factor Chemotherapy for Stage II Breast Cancer.

Malekzadeh P, Cowan K, Steinberg SM, Camphausen KA, Shriver C, Merino MJ, Good ML, Berman A, Danforth DN Jr.

Am J Clin Oncol. 2020 Jan 29. doi: 10.1097/COC.0000000000000667. [Epub ahead of print]


The Olfactory Bulb Provides a Radioresistant Niche for Glioblastoma Cells.

Timme CR, Degorre-Kerbaul C, McAbee JH, Rath BH, Wu X, Camphausen K, Tofilon PJ.

Int J Radiat Oncol Biol Phys. 2020 Jan 25. pii: S0360-3016(20)30066-3. doi: 10.1016/j.ijrobp.2020.01.007. [Epub ahead of print]


In Regard to Wallner et al.

Kang J, Thompson RF, Fuller CD, Camphausen KA, Gabriel PE, Thomas CR.

Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):217-218. doi: 10.1016/j.ijrobp.2019.10.044. No abstract available.


Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response.

Das S, Camphausen K, Shankavaram U.

Front Oncol. 2019 Oct 25;9:1136. doi: 10.3389/fonc.2019.01136. eCollection 2019.


SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment.

Deng X, Das S, Valdez K, Camphausen K, Shankavaram U.

Cancers (Basel). 2019 Oct 29;11(11). pii: E1682. doi: 10.3390/cancers11111682.


LXRβ controls glioblastoma cell growth, lipid balance, and immune modulation independently of ABCA1.

Patel D, Ahmad F, Kambach DM, Sun Q, Halim AS, Kramp T, Camphausen KA, Stommel JM.

Sci Rep. 2019 Oct 29;9(1):15458. doi: 10.1038/s41598-019-51865-8.


Comparison of Proteomic Biodosimetry Biomarkers Across Five Different Murine Strains.

Sproull M, Shankavaram U, Camphausen K.

Radiat Res. 2019 Dec;192(6):640-648. doi: 10.1667/RR15442.1. Epub 2019 Oct 16.


Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like Cells.

McAbee JH, Rath BH, Valdez K, Young DL, Wu X, Shankavaram UT, Camphausen K, Tofilon PJ.

Cancer Res. 2019 Dec 1;79(23):6032-6043. doi: 10.1158/0008-5472.CAN-19-2452. Epub 2019 Oct 15.


Circulating biomarkers for high-grade glioma.

Loo HK, Mathen P, Lee J, Camphausen K.

Biomark Med. 2019 Feb;13(3):161-165. doi: 10.2217/bmm-2018-0463. Epub 2019 Feb 26. No abstract available.


The Quiescent Metabolic Phenotype of Glioma Stem Cells.

Spehalski EI, Lee JA, Peters C, Tofilon P, Camphausen K.

J Proteomics Bioinform. 2019;12(6):96-103. doi: 10.35248/0974-276x.19.12.502. Epub 2019 Aug 13.


Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastoma.

Krauze AV, Mackey M, Rowe L, Chang MG, Holdford DJ, Cooley T, Shih J, Tofilon PJ, Camphausen K.

Neurooncol Pract. 2018 Nov;5(4):246-250. doi: 10.1093/nop/npy009. Epub 2018 Apr 16.


DiscoverSL: an R package for multi-omic data driven prediction of synthetic lethality in cancers.

Das S, Deng X, Camphausen K, Shankavaram U.

Bioinformatics. 2019 Feb 15;35(4):701-702. doi: 10.1093/bioinformatics/bty673.


Three-dimensional alginate hydrogels for radiobiological and metabolic studies of cancer cells.

Read GH, Miura N, Carter JL, Kines KT, Yamamoto K, Devasahayam N, Cheng JY, Camphausen KA, Krishna MC, Kesarwala AH.

Colloids Surf B Biointerfaces. 2018 Nov 1;171:197-204. doi: 10.1016/j.colsurfb.2018.06.018. Epub 2018 Jun 18.


The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo.

Wahba A, Rath BH, O'Neill JW, Camphausen K, Tofilon PJ.

Mol Cancer Ther. 2018 Aug;17(8):1717-1726. doi: 10.1158/1535-7163.MCT-17-1303. Epub 2018 Jun 4.


Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM.

Rowe LS, Butman JA, Mackey M, Shih JH, Cooley-Zgela T, Ning H, Gilbert MR, Smart DK, Camphausen K, Krauze AV.

J Neurooncol. 2018 Aug;139(1):145-152. doi: 10.1007/s11060-018-2855-z. Epub 2018 May 16.


Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.

Bristow RG, Alexander B, Baumann M, Bratman SV, Brown JM, Camphausen K, Choyke P, Citrin D, Contessa JN, Dicker A, Kirsch DG, Krause M, Le QT, Milosevic M, Morris ZS, Sarkaria JN, Sondel PM, Tran PT, Wilson GD, Willers H, Wong RKS, Harari PM.

Lancet Oncol. 2018 May;19(5):e240-e251. doi: 10.1016/S1470-2045(18)30096-2. Review.


The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and as Orthotopic Xenografts.

Timme CR, Rath BH, O'Neill JW, Camphausen K, Tofilon PJ.

Mol Cancer Ther. 2018 Jun;17(6):1207-1216. doi: 10.1158/1535-7163.MCT-17-1267. Epub 2018 Mar 16.


Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.

Rath BH, Waung I, Camphausen K, Tofilon PJ.

Mol Cancer Ther. 2018 May;17(5):1070-1078. doi: 10.1158/1535-7163.MCT-17-1053. Epub 2018 Feb 26.


Radiation-induced alternative transcripts as detected in total and polysome-bound mRNA.

Wahba A, Ryan MC, Shankavaram UT, Camphausen K, Tofilon PJ.

Oncotarget. 2017 Oct 9;9(1):691-705. doi: 10.18632/oncotarget.21672. eCollection 2018 Jan 2.


Correction to expert consensus on re-irradiation for recurrent glioma.

Krauze AV, Attia A, Braunstein S, Chan M, Combs SE, Fietkau R, Fiveash J, Flickinger J, Grosu A, Howard S, Nieder C, Niyazi M, Rowe L, Smart DD, Tsien C, Camphausen K.

Radiat Oncol. 2018 Jan 18;13(1):8. doi: 10.1186/s13014-018-0955-8.


Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma.

Hao S, Song H, Zhang W, Seldomridge A, Jung J, Giles AJ, Hutchinson MK, Cao X, Colwell N, Lita A, Larion M, Maric D, Abu-Asab M, Quezado M, Kramp T, Camphausen K, Zhuang Z, Gilbert MR, Park DM.

Neuro Oncol. 2018 May 18;20(6):799-809. doi: 10.1093/neuonc/nox241.


LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.

Ho WS, Sizdahkhani S, Hao S, Song H, Seldomridge A, Tandle A, Maric D, Kramp T, Lu R, Heiss JD, Camphausen K, Gilbert MR, Zhuang Z, Park DM.

Cancer Lett. 2018 Feb 28;415:217-226. doi: 10.1016/j.canlet.2017.11.035. Epub 2017 Dec 2.


Expert consensus on re-irradiation for recurrent glioma.

Krauze AV, Attia A, Braunstein S, Chan M, Combs SE, Fietkau R, Fiveash J, Flickinger J, Grosu A, Howard S, Nieder C, Niyazi M, Rowe L, Smart DD, Tsien C, Camphausen K.

Radiat Oncol. 2017 Dec 1;12(1):194. doi: 10.1186/s13014-017-0928-3. Erratum in: Radiat Oncol. 2018 Jan 18;13(1):8.


Biodosimetry: A Future Tool for Medical Management of Radiological Emergencies.

Sproull MT, Camphausen KA, Koblentz GD.

Health Secur. 2017 Nov/Dec;15(6):599-610. doi: 10.1089/hs.2017.0050. Epub 2017 Dec 1.


Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.

Krauze AV, Peters C, Cheng J, Ning H, Mackey M, Rowe L, Cooley-Zgela T, Smart DD, Camphausen K.

Radiat Oncol. 2017 Nov 29;12(1):191. doi: 10.1186/s13014-017-0930-9.


Quantitative imaging of pO2 in orthotopic murine gliomas: hypoxia correlates with resistance to radiation.

Yasui H, Kawai T, Matsumoto S, Saito K, Devasahayam N, Mitchell JB, Camphausen K, Inanami O, Krishna MC.

Free Radic Res. 2017 Oct;51(9-10):861-871. doi: 10.1080/10715762.2017.1388506.


Brain tumor segmentation using holistically nested neural networks in MRI images.

Zhuge Y, Krauze AV, Ning H, Cheng JY, Arora BC, Camphausen K, Miller RW.

Med Phys. 2017 Oct;44(10):5234-5243. doi: 10.1002/mp.12481. Epub 2017 Aug 20.


Optimizing the Benefit of CNS Radiation Therapy in the Pediatric Population-PART 2: Novel Methods of Radiation Delivery.

Rowe LS, Krauze AV, Ning H, Camphausen KA, Kaushal A.

Oncology (Williston Park). 2017 Mar 15;31(3):224-6, 228. Review.


Optimizing the Benefit of CNS Radiation Therapy in the Pediatric Population-PART 1: Understanding and Managing Acute and Late Toxicities.

Rowe LS, Krauze AV, Ning H, Camphausen KA, Kaushal A.

Oncology (Williston Park). 2017 Mar 15;31(3):182-8. Review.


Computational analysis of the mesenchymal signature landscape in gliomas.

Celiku O, Tandle A, Chung JY, Hewitt SM, Camphausen K, Shankavaram U.

BMC Med Genomics. 2017 Mar 9;10(1):13. doi: 10.1186/s12920-017-0252-7.


Multivariate Analysis of Radiation Responsive Proteins to Predict Radiation Exposure in Total-Body Irradiation and Partial-Body Irradiation Models.

Sproull M, Kramp T, Tandle A, Shankavaram U, Camphausen K.

Radiat Res. 2017 Feb;187(2):251-258. doi: 10.1667/RR14558.1. Epub 2017 Jan 24.


Mitotic Protein Kinase 1: Role in Spindle Assembly Checkpoint Revisited.

Tandle A, Camphausen K.

J Cancer Clin Trials. 2016 May;1(2). pii: 111. Epub 2016 May 2. No abstract available.


FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.

Maachani UB, Shankavaram U, Kramp T, Tofilon PJ, Camphausen K, Tandle AT.

Oncotarget. 2016 Nov 22;7(47):77365-77377. doi: 10.18632/oncotarget.12670.


State-of-the-Art Advances in Radiation Biodosimetry for Mass Casualty Events Involving Radiation Exposure.

Sproull M, Camphausen K.

Radiat Res. 2016 Nov;186(5):423-435. Epub 2016 Oct 6. Review.


A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer.

Zhen DB, Griffith KA, Ruch JM, Camphausen K, Savage JE, Kim EJ, Sahai V, Simeone DM, Zalupski MM.

Invest New Drugs. 2016 Dec;34(6):733-739. Epub 2016 Jul 21.


Polysome Profiling Links Translational Control to the Radioresponse of Glioblastoma Stem-like Cells.

Wahba A, Rath BH, Bisht K, Camphausen K, Tofilon PJ.

Cancer Res. 2016 May 15;76(10):3078-87. doi: 10.1158/0008-5472.CAN-15-3050. Epub 2016 Mar 22.


Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.

Rath BH, Wahba A, Camphausen K, Tofilon PJ.

Cancer Med. 2015 Nov;4(11):1705-16. doi: 10.1002/cam4.510. Epub 2015 Oct 30.


Molecular profiling of MPS1 gene silencing in U251 glioma cell line.

Shankavaram U, Maachani UB, Zhao S, Camphausen K, Tandle A.

Genom Data. 2015 Dec 1;6:36-39.


Analysis of radiation therapy in a model of triple-negative breast cancer brain metastasis.

Smart D, Garcia-Glaessner A, Palmieri D, Wong-Goodrich SJ, Kramp T, Gril B, Shukla S, Lyle T, Hua E, Cameron HA, Camphausen K, Steeg PS.

Clin Exp Metastasis. 2015 Oct;32(7):717-27. doi: 10.1007/s10585-015-9739-9. Epub 2015 Aug 30.


A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.

Krauze AV, Myrehaug SD, Chang MG, Holdford DJ, Smith S, Shih J, Tofilon PJ, Fine HA, Camphausen K.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):986-992. doi: 10.1016/j.ijrobp.2015.04.038. Epub 2015 Apr 30.


Serum Amyloid A as a Biomarker for Radiation Exposure.

Sproull M, Kramp T, Tandle A, Shankavaram U, Camphausen K.

Radiat Res. 2015 Jul;184(1):14-23. Epub 2015 Jun 26.


Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.

Jones GC, Kehrer JD, Kahn J, Koneru BN, Narayan R, Thomas TO, Camphausen K, Mehta MP, Kaushal A.

Clin Lung Cancer. 2015 Nov;16(6):413-30. doi: 10.1016/j.cllc.2015.04.001. Epub 2015 Apr 23. Review.


Modulation of miR-21 signaling by MPS1 in human glioblastoma.

Maachani UB, Tandle A, Shankavaram U, Kramp T, Camphausen K.

Oncotarget. 2016 Aug 16;7(33):52912-52927. doi: 10.18632/oncotarget.4143.


Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma.

Gordon IK, Lu J, Graves CA, Huntoon K, Frerich JM, Hanson RH, Wang X, Hong CS, Ho W, Feldman MJ, Ikejiri B, Bisht K, Chen XS, Tandle A, Yang C, Arscott WT, Ye D, Heiss JD, Lonser RR, Camphausen K, Zhuang Z.

Mol Cancer Ther. 2015 Jul;14(7):1540-1547. doi: 10.1158/1535-7163.MCT-14-0614. Epub 2015 May 4.


Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins.

Maachani UB, Kramp T, Hanson R, Zhao S, Celiku O, Shankavaram U, Colombo R, Caplen NJ, Camphausen K, Tandle A.

Mol Cancer Res. 2015 May;13(5):852-62. doi: 10.1158/1541-7786.MCR-14-0462-T. Epub 2015 Feb 26.


Current clinical trials testing combinations of immunotherapy and radiation.

Crittenden M, Kohrt H, Levy R, Jones J, Camphausen K, Dicker A, Demaria S, Formenti S.

Semin Radiat Oncol. 2015 Jan;25(1):54-64. doi: 10.1016/j.semradonc.2014.07.003. Review.

Supplemental Content

Loading ...
Support Center